Portfoliotracker

Celon Pharma S.A.

CLN.WA · WARSAW · Healthcare Drug Manufacturers - Specialty & Generic 61/100 C

15,38 PLN
▼ −0,42 (−2,66 %)
Trading
Price as of 17. 11. 15:03, fetched 17. 11. 15:22
Next earnings–
Ex-dividend–
Analysts–
50 / 200 day average– / –

Price

Portfoliotracker score61 / 100 Market cap780 mil. PLN P/E7,8 Forward P/E9,9 P/S– P/B1,6 EV/EBITDA4,1 Dividend yield– FCF yield-0,28 % EPS2,04 PLN Net margin41,5 % Return on equity24,2 % Beta0,60 Debt / equity0,26
52-week range 15,66 to 23,50
3-month average volume0,0 M

Finance

Where the revenue goes

Loading the income statement flow…

Fundamentals

Loading key figures…

Insiders, analysts and people

All trades and changes

Loading insiders, analysts and opinions…

Co se právě děje

AI souhrn
Objednat AI souhrn, co se u firmy právě děje Vytvoří se jednou na pozadí a pak ho uvidí všichni. Ve verzi Free 3 objednávky měsíčně.

About the company

Celon Pharma S.A., an integrated pharmaceutical company, engages in the research, manufacture, and marketing of specialised generic products. The company provides drugs to treat cancers, neurological diseases, diabetes, and other metabolic disorders. Celon Pharma S.A. was founded in 2002 and is based in Lomianki, Poland. The company operates as a subsidiary of Glatton Sp. z o.o.

Employees
560
Country
Poland
Data since
17. 2. 2017

Explore further

Similar companies NEU.WAPZU.WASLV.WAKRU.WA

Intraday chart

Your own portfolio, properties and finances in one place.

The account is free with no time limit. Only you see your data; nobody adds it up with others.

This is saved to your account. You can keep browsing, calculating and comparing without signing in.

Welcome back

Sign in and pick up where you left off.

or continue with

No account yet? Create a free account